Solid dosage form composition for buccal or sublingual administration of cannabinoids

A pharmaceutical composition, comprising:

• a pharmaceutically-acceptable adsorbent, and adsorbed thereto a cannabinoid solution comprising a mixture of ethanol and a cannabinoid selected from the group consisting of delta-9-tetrahydrocannabinol (THC), cannabidiol (CBD) and mixtures thereof;
• wherein
• the pharmaceutical composition is a solid dosage form;
• the solid dosage form is a tablet, powder, or film;
• dissolution of the cannabinoid occurs within 300 seconds in 0.1 M phosphate buffer, pH 6.8, with 2% polysorbate 20;
• the pharmaceutically-acceptable adsorbent is silica;
• the cannabinoid is present in an amount from about 0.1 mg to about 150 mg;
• and
• the weight/weight ratio of silica:cannabinoid solution is from about 1:0:0.5 to about 1.0:5.0;
• and
• the cannabinoid solution in the solid dosage form comprises from about 5 wt % to about 95 wt % of ethanol by weight of the cannabinoid solution.